SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001390478-20-000009
Filing Date
2020-03-13
Accepted
2020-03-13 08:35:47
Documents
2
Period of Report
2020-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sls-20200313x8xk.htm 8-K 42591
2 EXHIBIT 99.1 sls-20200313x8xkex991.htm EX-99.1 27727
  Complete submission text file 0001390478-20-000009.txt   71764
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 20710804
SIC: 2834 Pharmaceutical Preparations